You are not logged in.You can comment without logging in, but your comment will appear as from "Anonymous".Log in to associate your identity with your comment.Warning: If you want to log in, you should do so now. Otherwise, you may need to retype your comment.If you do not have an account, you can register here.
Judge requests mass tort status for Yaz, Yasmin, and Ocella Contraceptives
Mass Tort Status Requested for Yaz, Yasmin and Ocella Contraceptives, by New Jersey Judge
According to a report on Law.com, New Jersey Judge Donald Volkert, Jr. has asked the New Jersey judiciary to consolidate a number of cases stemming from strokes and other serious health complications suffered by women who have taken the oral contraceptives Yaz, Yasmin, and Ocella. Those products are manufactured and marketed by Bayer Healthcare Pharmaceuticals and Teva Pharmaceuticals.
Yaz, Yasmin and Ocella Can Higher Risk of Pulmonary Embolism
Yaz, Yasmin, and Ocella all contain Drospirenone, a chemical ingredient not present in other oral contraceptives. A recent study from the British Medical Journal has shown a higher risk of certain health complications from contraceptives with drospirenone.
Judge Volkert’s application suggests the consolidation would aid in efficiently resolving the claims.